chx
Lv2
200 积分
2023-08-16 加入
-
Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial
5天前
已完结
-
Placebo effect on progression and regression in NASH: Evidence from a meta‐analysis
14天前
已完结
-
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
1个月前
已完结
-
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
2个月前
已完结
-
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
2个月前
已完结
-
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
2个月前
已完结
-
Thiazolidinediones, Peripheral Edema, and Type 2 Diabetes: Incidence, Pathophysiology, and Clinical Implications
3个月前
已完结
-
Comparison between the Effect of empagliflozin and pioglitazone added to metformin in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
3个月前
已完结
-
A phase 2, adaptive randomized, double-blind, placebo-controlled, multicenter, 52-week study of HM15211 in patients with biopsy-confirmed non-alcoholic steatohepatitis – Study design and rationale of HM-TRIA-201 study
5个月前
已完结
-
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
6个月前
已完结